Clinical Trial Update: A Trial to Investigate the Safety and the Pharmacokinetic, Pharmacodynamic Characteristics of Two BioChaperone® Glucagon Formulations Compared to Marketed GlucaGen® in Subjects With T1DM [Phase 1]

View source ↗

Summary

Phase 1 study comparing two BioChaperone glucagon formulations to marketed GlucaGen in adults with Type 1 Diabetes Mellitus to evaluate safety, pharmacokinetics…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• BioChaperone Glucagon Formulation A (glucagon)
• BioChaperone Glucagon Formulation B (glucagon)
• GlucaGen (glucagon)

Snippet

Sponsor: Adocia | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: COMPLETED